Clinical trial
Evaluation of the Safety and Effectiveness of the Circle SAFE System for Diaphragmatic Compound Motor Action Potential (CMAP) Recording and Display of Patients Undergoing Pulmonary Vein Ablation Procedures. The SAFE-CMAP Clinical Trial
NCT07820631 is registered in ClinicalTrials.gov with Circle Safe, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Effectiveness of the Circle SAFE System for Diaphragmatic Compound Motor Action Potential (CMAP) Recording and Display of Patients Undergoing Pulmonary Vein Ablation Procedures. The SAFE-CMAP Clinical Trial
- Lead sponsor
- Circle Safe, Inc.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 17, 2026
- Completion date
- October 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.